Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
September 25, 2007
An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals
Edward J Delaney
The AAPS Journal
|
November 25, 2024
Recommendation for Clarifying FDA Policy in Evaluating "Sameness" of Higher Order Structure for Generic Peptide Therapeutics
Jessica A Rogers-Crovak, Edward J Delaney, David J Detlefsen
The Journal of Organic Chemistry
|
April 17, 2007
Synthesis of Z-5-carboxymethylene-1,3-dioxolan-4-ones: a better way
Keming Zhu, James H Simpson, Edward J Delaney, et al.
Clinics in Laboratory Medicine
|
April 10, 2007
A 21st century HPLC workflow for process R&D
Brent D Karcher, Merrill L Davies, Edward J Delaney, et al.
Chemical Reviews
|
July 14, 2006
Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry
A Erik Rubin, Srinivas Tummala, Douglas A Both, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Regulatory Toxicology and Pharmacology : RTP
|
September 25, 2007
An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals
Edward J Delaney
The AAPS Journal
|
November 25, 2024
Recommendation for Clarifying FDA Policy in Evaluating "Sameness" of Higher Order Structure for Generic Peptide Therapeutics
Jessica A Rogers-Crovak, Edward J Delaney, David J Detlefsen
The Journal of Organic Chemistry
|
April 17, 2007
Synthesis of Z-5-carboxymethylene-1,3-dioxolan-4-ones: a better way
Keming Zhu, James H Simpson, Edward J Delaney, et al.
Clinics in Laboratory Medicine
|
April 10, 2007
A 21st century HPLC workflow for process R&D
Brent D Karcher, Merrill L Davies, Edward J Delaney, et al.
Chemical Reviews
|
July 14, 2006
Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry
A Erik Rubin, Srinivas Tummala, Douglas A Both, et al.
Page
of 1